Curcumin reduces the overexpression of flap endonuclease 1 (FEN1), an enzyme associated with cisplatin-resistance in breast cancer cells, thereby increasing the sensitivity of cancer cells to this chemotherapeutic agent [27]. Here, FEN1 is linked to breast carcinoma.